JDP2 and breast cancer: Online Kaplan–Meier plotter analysis revealed that patients with high JDP2 expression in ovarian, lung, gastric, or breast cancer had significantly shorter progression-free survival and shorter overall survival than patients with low JDP2 expression (Fig. 7a, b), suggesting that a higher JDP2 level correlated with cancer relapse and poorer patient outcome.